---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-051196"
form_type: "8-K"
ticker: "CING"
cik: "0001862150"
company_name: "Cingulate Inc."
filed_at: "2024-12-23T23:59:59+00:00"
generated_at: "2026-05-28T23:48:33.976104+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cingulate raises $5M via 9% promissory note; cash runway into Q4 2025, NDA target mid-2025

## Summary
- Net proceeds of $5.0M from $5.48M unsecured note (9% interest, 18-month maturity, $450K OID).
- Cash runway extended to Q4 2025; NDA submission for CTx-1301 targeted for mid-2025.
- Lender Streeterville Capital; monthly redemption cap $550K from July 2025; default triggers 15%/5% balance increases.
- Guarantees from subsidiaries Cingulate Therapeutics LLC and Cingulate Works, Inc.

## SEC filing metadata
- accession: 0001493152-24-051196
- form_type: 8-K
- ticker: CING
- cik: 0001862150
- company_name: Cingulate Inc.
- filed_at: 2024-12-23T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1862150/000149315224051196/0001493152-24-051196-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1862150/000149315224051196/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-051196
- JSON: https://secwatch.observer/filing/0001493152-24-051196.json
- Plain text: https://secwatch.observer/filing/0001493152-24-051196.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.